Singapore markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.4290+0.0090 (+0.63%)
At close: 02:02PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
31/03/2019
Total revenue
92,265
76,701
79,660
52,432
25,363
Cost of revenue
41,562
38,774
37,655
22,990
10,380
Gross profit
50,703
37,927
42,005
29,442
14,983
Operating expenses
Research development
3,386
5,873
4,596
1,098
-
Selling general and administrative
45,557
44,032
36,172
28,934
15,615
Total operating expenses
49,320
50,303
41,274
30,482
15,664
Operating income or loss
1,383
-12,376
731
-1,041
-680.6943
Interest expense
12,709
12,223
9,819
6,442
2,904
Total other income/expenses net
2,380
20,779
-22,416
3,254
-1,295
Income before tax
-8,946
-3,820
-31,501
-5,188
-4,719
Income tax expense
1,619
-941
-3,237
-790.4386
166.2867
Income from continuing operations
-10,565
-2,879
-28,264
-4,397
-4,885
Net income
-10,565
-2,879
-28,264
-4,397
-4,885
Net income available to common shareholders
-10,565
-2,879
-28,264
-4,397
-4,885
Basic EPS
-
-0.15
-1.86
-0.30
-0.49
Diluted EPS
-
-0.15
-1.86
-0.30
-0.49
Basic average shares
-
19,454
15,197
14,360
9,909
Diluted average shares
-
19,454
15,197
14,360
9,909
EBITDA
-
14,548
-15,704
4,961
119.3342